Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBritish American Tobacco Regulatory News (BATS)

Share Price Information for British American Tobacco (BATS)

Share Price is delayed by 15 minutes
Get Live Data
4,409.00    -53.00 (-1.19%)
Bid:
4,409.00
Ask:
4,410.00
Spread: 1.00 (0.023%)
Market Cap: £95.18b
BATS Live PriceLast checked at - London Stock Exchange

Intraday British American Tobacco Share Chart

Result of AGM

16 Apr 2025 16:45

RNS Number : 3443F
British American Tobacco PLC
16 April 2025
 

16 April 2025

 

BRITISH AMERICAN TOBACCO p.l.c. (the "Company")

 

RESULTS OF VOTING AT THE 2024 ANNUAL GENERAL MEETING

British American Tobacco p.l.c. (the 'Company') announces the result of voting on the resolutions at its Annual General Meeting ('AGM') held on Wednesday 16 April 2025 at the Hilton London Bankside, 2-8 Great Suffolk St, London, SE1 0UG. The full text of the resolutions, along with the explanatory notes, is set out in the Notice of Annual General Meeting dated 5 March 2025.

 

The table below sets out the results of the poll on each of the total of 21 Resolutions as stated in the Notice of Meeting dated 5 March 2025. All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll taken at the Meeting. Each shareholder, present in person or by proxy, was entitled to one vote per ordinary share of 25p held.

 

Resolution

Votes For

% of votes cast

Votes against

% of votes cast

Votes Withheld

Votes cast in total

 Total cast as a % of issued share capital

1. Receipt of 2024 Report and Accounts

1,604,423,816

99.81%

3,007,431

0.19%

3,727,349

1,607,431,247

73.02%

2. Approval of the 2025 Directors' Remuneration Policy

1,582,103,742

98.32%

27,065,379

1.68%

1,989,473

1,609,169,121

73.10%

3. Approval of the 2024 Directors' Remuneration Report

1,584,560,241

98.46%

24,754,103

1.54%

1,844,248

1,609,314,344

73.10%

4.Reappointment of KPMG LLP as Auditors

1,551,037,131

96.35%

58,722,742

3.65%

1,398,723

1,609,759,873

73.12%

5. Authority for the Audit Committee to agree the Auditors' remuneration

1,602,760,781

99.57%

6,899,212

0.43%

1,498,603

1,609,659,993

73.12%

6. Re-election of Luc Jobin as a Director

1,585,632,252

98.53%

23,591,640

1.47%

1,934,702

1,609,223,892

73.10%

7. Re-election of Tadeu Marroco as a Director

1,603,357,945

99.61%

6,240,594

0.39%

1,560,056

1,609,598,539

73.11%

8. Re-election of Kandy Anand as a Director

1,596,545,940

99.26%

11,873,084

0.74%

2,739,571

1,608,419,024

73.06%

9. Re-election of Karen Guerra as a Director

1,601,724,941

99.58%

6,716,268

0.42%

2,717,386

1,608,441,209

73.06%

10. Re-election of Holly Keller Koeppel as a Director

1,551,330,018

96.45%

57,143,008

3.55%

2,685,569

1,608,473,026

73.06%

11. Re-election of Véronique Laury as a Director

1,601,623,862

99.58%

6,765,405

0.42%

2,769,328

1,608,389,267

73.06%

12. Re-election of Darrell Thomas as a Director

1,601,715,479

99.58%

6,704,923

0.42%

2,738,193

1,608,420,402

73.06%

13. Re-election of Serpil Timuray as a Director

1,592,901,711

99.04%

15,484,508

0.96%

2,771,133

1,608,386,219

73.06%

14. Election of Soraya Benchikh as a Director

1,607,591,937

99.88%

1,921,986

0.12%

1,644,673

1,609,513,923

73.11%

15. Election of Uta Kemmerich-Keil as a Director

1,605,979,952

99.85%

2,412,034

0.15%

2,764,609

1,608,391,986

73.06%

16. Authority to make donations to political organisations and to incur political expenditure

1,499,201,368

93.14%

110,377,277

6.86%

1,579,950

1,609,578,645

73.11%

17. Renewal of Directors' authority to allot shares

1,511,285,703

93.89%

98,348,344

6.11%

1,524,383

1,609,634,047

73.12%

18. Establishment of Performance Share Plan

1,584,522,405

98.44%

25,077,326

1.56%

1,557,360

1,609,599,731

73.11%

19. Renewal of Directors' authority to disapply pre-emption rights

1,485,012,776

92.28%

124,287,266

7.72%

1,858,554

1,609,300,042

73.10%

20. Authority for the Company to make market purchases of ordinary shares

1,605,790,686

99.78%

3,503,243

0.22%

1,864,666

1,609,293,929

73.10%

21. Notice period for General Meetings

1,538,821,590

95.60%

70,884,506

4.40%

1,452,499

1,609,706,096

73.12%

 

All resolutions were passed at the Company's AGM today with the requisite majority of votes.

 

The number of ordinary shares in issue (excluding Treasury shares) at the close of business on Monday 14 April 2025 was 2,201,463,243. Shareholders are entitled to one vote per share. A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes 'For' or 'Against' a resolution. All valid proxy votes (whether submitted electronically or in hard copy form) were included in the poll. Proxy appointments which gave discretion to the Chair have been included in the total votes 'for' the respective resolutions.

 

In accordance with UK Listing Rules 6.4.1 and 6.4.2, copies of Resolutions 17 and 19 to 21 have been submitted to the Financial Conduct Authority, and will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

C Worlock

Assistant Secretary

British American Tobacco p.l.c.

 

 

Enquiries:

 

British American Tobacco Media Centre

+44 (0)20 7845 2888 (24 hours) │@BATPlc

 

Investor Relations

Victoria Buxton: +44 (0)20 7845 2012 | IR_team@bat.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFLFIMEISEDL
Date   Source Headline
6th Jul 202612:30 pmRNSTransaction in Own Shares
3rd Jul 202611:30 amRNSDirector/PDMR Shareholding
1st Jul 202612:05 pmRNSIssue of Shares
1st Jul 202612:00 pmRNSTotal Voting Rights
30th Jun 20267:00 amRNSBranch Register: Dividend Finalisation Information
29th Jun 202612:00 pmRNSTransaction in Own Shares
26th Jun 202611:45 amRNSDirector/PDMR Shareholding
26th Jun 20267:00 amRNSShare Buyback Programme
22nd Jun 202610:00 amRNSTransaction in Own Shares
19th Jun 202611:00 amRNSDirector/PDMR Shareholding
15th Jun 202612:00 pmRNSTransaction in Own Shares
8th Jun 202612:30 pmRNSTransaction in Own Shares
8th Jun 202612:00 pmRNSDirector/PDMR Shareholding
5th Jun 20263:15 pmRNSDirector/PDMR Shareholding
4th Jun 20262:30 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNS2026 H1 Pre-Close Trading Update
1st Jun 202612:20 pmRNSIssue of Shares
1st Jun 202612:15 pmRNSTotal Voting Rights
1st Jun 202612:00 pmRNSTransaction in Own Shares
27th May 20264:15 pmRNSDirector/PDMR Shareholding
26th May 20263:00 pmRNSDirector/PDMR Shareholding
26th May 20261:15 pmRNSTransaction in Own Shares
21st May 20264:30 pmRNSDirector Declaration
18th May 20263:00 pmRNSDirector/PDMR Shareholding
18th May 202612:00 pmRNSTransaction in Own Shares
13th May 202612:00 pmRNSDirector/PDMR Shareholding
11th May 202611:45 amRNSAdmission to Trading
11th May 202611:30 amRNSTransaction in Own Shares
8th May 20264:30 pmRNSDirector/PDMR Shareholding
8th May 20264:25 pmRNSDirector/PDMR Shareholding
8th May 20264:20 pmRNSDirector/PDMR Shareholding
8th May 202610:55 amRNSDirector/PDMR Shareholding
8th May 202610:50 amRNSDirector/PDMR Shareholding
7th May 20266:15 pmRNSPublication of Final Terms
5th May 20262:15 pmRNSTransaction in Own Shares
5th May 202611:00 amRNSDirector/PDMR Shareholding
1st May 202611:50 amRNSIssue of Shares
1st May 202611:45 amRNSTotal Voting Rights
30th Apr 20263:45 pmRNSDirector/PDMR Shareholding
27th Apr 202612:00 pmRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:05 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSShare Buyback Programme
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 202610:15 amRNSDirector/PDMR Shareholding
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20263:30 pmRNSResult of AGM
15th Apr 202611:45 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.